• Info
  • Insider Ownership

Insider Trading & Ownership of Anthony G. Quinn

Location
Cambridge, MA
Summary
The estimated net worth of Anthony G. Quinn is at least $855,352 dollars as of 09 Feb 2026. Anthony G. Quinn is the President & CEO, Director of Aeglea BioTherapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $580K. Anthony G. Quinn is the Director of Generation Bio Co. and owns shares of Generation Bio Co. (GBIO) stock worth about $275.4K.
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Anthony G. Quinn files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Anthony G. Quinn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Aeglea BioTherapeutics, Inc. President & CEO, Director $579,952 16 Mar 2022
GBIO Generation Bio Co. Director $275,400 09 Feb 2026
KLDO Kaleido Biosciences, Inc. Director 30 Jun 2021

Insider Transactions Reported by Anthony G. Quinn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.